BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9302497)

  • 1. Protein kinase C signalling in pancreatic beta-cells: cellular and molecular approaches.
    Persaud SJ
    Digestion; 1997; 58 Suppl 2():86-92. PubMed ID: 9302497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical isoforms of pKc and insulin secretion from pancreatic beta-cells: evidence using Gö 6976 and Ro 31-8220 as Pkc inhibitors.
    Harris TE; Persaud SJ; Jones PM
    Biochem Biophys Res Commun; 1996 Oct; 227(3):672-6. PubMed ID: 8885992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense oligonucleotides targeting protein kinase C-alpha, -beta I, or -delta but not -eta inhibit lipopolysaccharide-induced nitric oxide synthase expression in RAW 264.7 macrophages: involvement of a nuclear factor kappa B-dependent mechanism.
    Chen CC; Wang JK; Lin SB
    J Immunol; 1998 Dec; 161(11):6206-14. PubMed ID: 9834107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase C as a drug target: implications for drug or diet prevention and treatment of cancer.
    Carter CA
    Curr Drug Targets; 2000 Sep; 1(2):163-83. PubMed ID: 11465069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudosubstrate peptide inhibitors of beta-cell protein kinases: altered selectivity after myristoylation.
    Harris TE; Persaud SJ; Jones PM
    Mol Cell Endocrinol; 1999 Sep; 155(1-2):61-8. PubMed ID: 10580839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium and protein kinase C (PKC)-related kinase mediate alpha 1A-adrenergic receptor-stimulated activation of phospholipase D in rat-1 cells, independent of PKC.
    Parmentier JH; Ahmed A; Ruan Y; Gandhi GK; Saeed AE; Malik KU
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1206-15. PubMed ID: 12438545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct PKC isoforms mediate the activation of cPLA2 and adenylyl cyclase by phorbol ester in RAW264.7 macrophages.
    Lin WW; Chen BC
    Br J Pharmacol; 1998 Dec; 125(7):1601-9. PubMed ID: 9884090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of human basophil histamine release by protein kinase C inhibitors differs with secretagogue and with inhibitor.
    Bergstrand H; Lundquist B; Karabelas K; Michelsen P
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1028-37. PubMed ID: 1372047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase C and the regulation of insulin secretion from pancreatic B cells.
    Jones PM; Persaud SJ; Howell SL
    J Mol Endocrinol; 1991 Apr; 6(2):121-7. PubMed ID: 2043240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CGP 41251 and tamoxifen selectively inhibit mitogen-activated protein kinase activation and c-Fos phosphoprotein induction by substance P in human astrocytoma cells.
    Luo W; Sharif TR; Houghton PJ; Sharif M
    Cell Growth Differ; 1997 Nov; 8(11):1225-40. PubMed ID: 9372245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase C (PKC) isoforms in cancer, tumor promotion and tumor suppression.
    Isakov N
    Semin Cancer Biol; 2018 Feb; 48():36-52. PubMed ID: 28571764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose-induced TGF-beta1 and TGF-beta receptor-1 expression in vascular smooth muscle cells is mediated by protein kinase C-alpha.
    Lindschau C; Quass P; Menne J; Güler F; Fiebeler A; Leitges M; Luft FC; Haller H
    Hypertension; 2003 Sep; 42(3):335-41. PubMed ID: 12939231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of protein kinase C-epsilon in inositol hexakisphosphate-induced exocytosis in mouse pancreatic beta-cells.
    Høy M; Berggren PO; Gromada J
    J Biol Chem; 2003 Sep; 278(37):35168-71. PubMed ID: 12837755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PKC zeta enhances insulin-like growth factor 1-dependent mitogenic activity in the rat clonal beta cell line RIN 1046-38.
    Hennige AM; Fritsche A; Strack V; Weigert C; Mischak H; Borboni P; Renn W; Häring HU; Kellerer M
    Biochem Biophys Res Commun; 2002 Jan; 290(1):85-90. PubMed ID: 11779137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of PKC-isoform-specific biological actions using pharmacological approaches.
    Way KJ; Chou E; King GL
    Trends Pharmacol Sci; 2000 May; 21(5):181-7. PubMed ID: 10785652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure of normal human melanocytes to a tumor promoting phorbol ester reverses growth suppression by transforming growth factor beta.
    Stavroulaki M; Kardassis D; Chatzaki E; Sakellaris G; Lindschau C; Haller H; Tosca A; Krasagakis K
    J Cell Physiol; 2008 Feb; 214(2):363-70. PubMed ID: 17654516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of phorbol ester and platelet-derived growth factor on protein kinase C in rat hepatic stellate cells.
    Kobayashi Y; Bridle KR; Ramm GA; O'neill R; Britton RS; Bacon BR
    Liver Int; 2007 Oct; 27(8):1066-75. PubMed ID: 17845534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definition by specific antisense oligonucleotides of a role for protein kinase C alpha in expression of differentiation markers in normal and neoplastic mouse epidermal keratinocytes.
    Lee YS; Dlugosz AA; McKay R; Dean NM; Yuspa SH
    Mol Carcinog; 1997 Jan; 18(1):44-53. PubMed ID: 9022812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of arginine-vasopressin-induced Ca2+ oscillations in beta-cells (HIT-T15): a role for oscillating protein kinase C.
    Schaefer M; Mischak H; Schnell S; Griese A; Iakubov R; Riepenhausen G; Schöfl C
    Endocrinology; 2004 Oct; 145(10):4635-44. PubMed ID: 15242987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phorbol 12-myristate 13-acetate and serum synergize to promote rapamycin-insensitive cell proliferation via protein kinase C-eta.
    Martin PM; Aeder SE; Chrestensen CA; Sturgill TW; Hussaini IM
    Oncogene; 2007 Jan; 26(3):407-14. PubMed ID: 16832347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.